Am J Kidney Dis. 2022 Feb;79(2):244-256.e1.PMID: 34029680P：T2DM＋CKD、尿中Alb/Cre300-5000以上E：カナグリフロジンC：プラセボO：腎関連有害事象発生率【結果】HR:0.70(0.61-0.82) P＜0.001重篤 HR:0.72(0.51-1.00) P=0.05AKI HR:0.85(0.64-1.13) P=0.…